An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma
Related Research units
Bibliographical data
Original language | English |
---|---|
ISSN | 1042-8194 |
DOIs | |
Publication status | Published - 2023 |
PubMed | 37497883 |
---|